Recently, the soluble form of PD-L1 (sPD-L1) has been measured in the peripheral blood of cancer patients, and several clinical investigations have investigated the predictive, prognostic, and regulatory roles of sPD-L1 levels in various malignancies [18–25]. The gene discussed is SPDL1; the disease is cancer.